Data Management in the World of Gen AI with Willem Koenders
Generative AI, in various ways, represents the next wave of technology.
AI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 27
Generative AI, in various ways, represents the next wave of technology.
The February 2024 edition of AIM Research Monthly paints a vivid picture of Enterprise AI's evolution, with a diverse range of articles revealing an industry that is dynamically shaping the future.
Elsevier launches Scopus AI, a generative AI tool transforming research with the world's largest database of scientific literature, enhancing insights and collaboration.
In a recent announcement, Hawaii’s independent Blue Cross and Blue Shield licensee, HMSA, welcomed David Dobbs as the Vice President and Chief Data Officer (CDO).
GigXR and CAE Healthcare unite to revolutionize healthcare training with advanced, AI-driven multimodal simulation.
LLMs have the potential to revolutionize the way enterprises operate, however, challenges exist - ranging from ethical concerns and bias to issues related to data privacy, interpretability, security, fairness, and regulatory compliance.
Discover the Top 10 Most Influential Data & Analytics Leaders in the USA's Healthcare Sector for 2024 – Pioneers Transforming Healthcare with AI and Data-Driven Strategies.
Understanding the phenomenon of hallucinations, their causes, and preventive measures becomes crucial to preserving users' trust in GenAI applications.
Deloitte expands its Quartz AI™ suite with the launch of Atlas AI™, a groundbreaking Generative AI solution for drug discovery, combining NVIDIA BioNeMo cloud APIs with Deloitte’s expertise to revolutionize and accelerate the drug development process.
Reveal's 'Ask' is set to redefine the legal landscape, offering an unprecedented level of efficiency and insight in legal data analysis. This launch marks a new chapter in the integration of AI in the legal sector, demonstrating Reveal's commitment to innovative and practical AI solutions.
Generate:Biomedicines revolutionizes drug development with its groundbreaking clinical pipeline and expanded Amgen collaboration, leveraging generative AI to transform the future of medicine.
Deepcell marks a new era in life sciences with its AI-powered REM-I platform, revolutionizing single cell analysis and research.
Melanie Shipek has been appointed as the Chief Analytics Officer at MUSC Health, bringing over 15 years of leadership experience in healthcare data and financial analysis.
Atropos Health, a trailblazer in transforming real-world clinical data into personalized evidence, has unveiled its strategic partnership with Arcadia, a leading healthcare data platform.
This issue, rich in AI and data analytics insights, is a testament to our commitment to delivering the latest trends and in-depth knowledge in the field. From profiling top data leaders in pharma to exploring emerging AI trends for 2024, we aim to provide content that both informs and inspires. It's a privilege to contribute to a publication that navigates the evolving landscapes of AI and data technology, offering our readers valuable insights and perspectives.
Merck's AIDDISON™ revolutionizes drug discovery, merging AI and machine learning to streamline synthesis and elevate new therapy success rates.
A curated list of top industry leaders who are redefining the future of pharmaceuticals through their innovative use of data, analytics, and technology.
Divya Pathak has been appointed as the Chief Data Officer at NYC Health + Hospitals, marking a significant milestone in her career.
The AI revolution offers immense potential, demanding proactive, responsible approaches to shape a future of opportunities and challenges.
BMC enhances its BMC Helix Service Management solution with cutting-edge generative AI, low code/no code development, and contextual tools, setting a new standard in AI-driven service and operations management.